A single-institution experience of performing bloodless transplant in Jehovah's Witness patients
Objective/Background: Autologous stem cell transplant has been shown to prolong survival in multiple myeloma (MM). A common complication of the pre-transplant conditioning chemotherapy is severe multi-lineage cytopenias, resulting in significant transfusion requirements. Jehovah's Witnesses are...
Main Authors: | Alexander Coltoff, Aditya Shreenivas, Solmaz Afshar, Amir Steinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387618301171 |
Similar Items
-
Liver transplantation in Jehovah’s witnesses: 13 consecutive cases at a single institution
by: Diego Costanzo, et al.
Published: (2020-01-01) -
Letter to the editor concerning “Single-institution experience of performing bloodless transplant in Jehovah’s Witness patients” by Coltoff A, Aditya S, Solmaz A, and Steinberg A. (Hematol oncol stem cell ther 2019;12(1):44–9.)
by: Jennifer C. Zhao, et al.
Published: (2021-03-01) -
Jehovah’s Witnesses as Patients
by: David Michaels
Published: (2016-04-01) -
Liver transplantation in Jehovah's Witnesses: two cases report
by: Ju-Young Jeong, et al.
Published: (2017-06-01) -
Should Jehovah’s Witness patients be listed for heart transplantation?
by: Elsayed Elmistekawy, et al.
Published: (2014-03-01)